Tivic Health Systems Inc. (TIVC)
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
SELLAS Life Sciences Group Inc. (SLS)
Alaunos Therapeutics Inc (TCRT)
RenovoRx Inc. (RNXT)
RenovoRx To Announce Promising New Clinical Data Using itsTAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
GeneDx Holdings (WGSWW)
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
Laboratory Corporation of America Holdings (LH)
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
Ardelyx Inc. (ARDX)
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
Allogene Therapeutics Inc (ALLO)
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
ALX Oncology Inc (ALXO)
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
Xilio Therapeutics Inc. (XLO)
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
GeneDx Holdings (WGS)
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
Veeva Systems Inc (VEEV)
Veeva and BioMarin Form Long-Term Strategic Partnership
Ventyx Biosciences (VTYX)
VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders